@biden_worldnewsModerna stock jumped 130% following a successful human trial for its skin cancer vaccine. The treatment proved effective even for late-stage melanoma patients.
Ver publicación original@biden_worldnewsModerna stock jumped 130% following a successful human trial for its skin cancer vaccine. The treatment proved effective even for late-stage melanoma patients.
Ver publicación originalFoto de @biden_worldnews· Aug 19, 2026· Foto 1 de 2· Moderna
A gloved hand holds a small glass vial filled with a pink liquid. The image has a clinical, sterile aesthetic. The focus is on the vial and the hand, with a blurred background suggesting a laboratory setting.
@biden_worldnewsModerna stock jumped 130% following a successful human trial for its skin cancer vaccine. The treatment proved effective even for late-stage melanoma patients.
Ver publicación originalFoto de @biden_worldnews· Aug 19, 2026· Foto 1 de 2· Moderna
A gloved hand holds a small glass vial filled with a pink liquid. The image has a clinical, sterile aesthetic. The focus is on the vial and the hand, with a blurred background suggesting a laboratory setting.